This volume contains the proceedings of the 14th Colloque Médecine et Recherche of the Fondation Ipsen pour la Recherche Thérapeutique devoted to Alzheimer's Disease and dedicated to the epidemiological study of this dementia, a very important issue because the incidence and prevalence of Alzheimer's Disease rise exponentially with age. Epidemiological findings not only confirm dementia as a major challenge for the coming years but also contribute defining risk factors, predicting and may be preventing this disease.
The book series in which this volume by Mayeux and Christen has been published brings the latest results of well-known scientists in the field of Alzheimer's disease research. In this volume different aspects ranging from costs to risk factors, genes, drugs and prevention are dealt with. TOC:Katzmann/Fox: The world-wide impact of dementia. Projections of prevelance and costs.-Mayeux: Predicting who will develop Alzheimer's disease.-Tol/Slooter/van Duijn: Genetic factors in early- and late-onset Alzheimer's disease.-Radebaugh/Ganguli/Khachaturian: Heterogeneity in Alzheimer's disease: Implications for Epidemiology.-Henderson:The epidemiology of Alzheimer's disease: The role of estrogen in reducing risk.-Kawas: Inflammation, anti-inflammatory drugs and Alzheimer's disease and other contributions.
The book series in which this volume by Mayeux and Christen has been published brings the latest results of well-known scientists in the field of Alzheimer's disease research. In this volume different aspects ranging from costs to risk factors, genes, drugs and prevention are dealt with. TOC:Katzmann/Fox: The world-wide impact of dementia. Projections of prevelance and costs.-Mayeux: Predicting who will develop Alzheimer's disease.-Tol/Slooter/van Duijn: Genetic factors in early- and late-onset Alzheimer's disease.-Radebaugh/Ganguli/Khachaturian: Heterogeneity in Alzheimer's disease: Implications for Epidemiology.-Henderson:The epidemiology of Alzheimer's disease: The role of estrogen in reducing risk.-Kawas: Inflammation, anti-inflammatory drugs and Alzheimer's disease and other contributions.